Nova Point Capital, LLC Abb Vie Inc. Transaction History

Nova Point Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 27, 2020	SELL	$85.91 - $100.83 $1.42 Million - $1.67 Million	-16,522 Closed	0 $0
Q2 2020 Aug 07, 2020	BUY	$73.37 - $98.18 $59,796 - $80,016	815 Added 5.19%	16,522 $1.62 Million
Q1 2020 Jun 18, 2020	BUY	$64.5 - $97.79 $8,062 - $12,223	125 Added 0.8%	15,707 $1.2 Million
Q4 2019 Jun 18, 2020	BUY	$72.13 - $90.25 $1.12 Million - $1.41 Million	15,582 New	15,582 $1.38 Million

3,653

1.24B

15.5M

11.6M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $296B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Nova Point Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Nova Point Capital, LLC with notifications on news.